APC and colorectal carcinoma: To exclude variation in chemotherapy response due to CRC subtype differences, we made use of the Marisa dataset and selected the microsatellite stable epithelial subtypes CMS2 and CMS3 (n = 119), which almost invariably carry an APC mutation and are therefore representative of the observed APC-driven decrease in BCL-2 expression.